Palisade Bio (NASDAQ:PALI) reported quarterly losses of $(0.08) per share. This is a 119.05 percent decrease over earnings of $0.42 per share from the same period last year.
Why NLS Pharmaceutics Shares Tumbled Over 66%; Here Are 68 Biggest Movers From Yesterday
Gainers
PepGen Inc. (NASDAQ: PEPG) jumped 110.2% to close at $10.93 after the company announced results from its Phase 1 healthy volunteer trial of PGN-EDO51 for Duchenne Muscular Dystrophy. The trial met its primary endpoint.
